Metabolic ratios of four probes of CYP2D6 in Turkish subjects: A cross-over study

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 21, Issue 4, 1996, Pages 309-314

  Bozkurt, A ^a   Basci N B ^a   Isimer A ^b   Sayal, A ^b   Kayaalp, S O ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Debrisoquine; Dextromethorphan; Metoprolol; Oxidation polymorphism; Sparteine; Turkish population

Indexed keywords

DEBRISOQUINE; DEXTROMETHORPHAN; METOPROLOL TARTRATE; SPARTEINE;

ADULT; ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG EXCRETION; DRUG METABOLISM; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; ORAL DRUG ADMINISTRATION; TURKEY (REPUBLIC);

EID: 0030485638     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03189732     Document Type: Article

References (17)

1. Eichelbaum M., Gross A.S. (1990) : The genetic polymorphism of debrisoquine sparteine metabolism - clinical aspects. Pharmacol. Ther., 46, 377-394.
2. Horai Y., Ishizaki T., Taga J., Ishikawa K. (1990) : Correlation among the metabolic ratios of three test probes (metoprolol, debrisoquine and sparteine) for genetically determined oxidation polymorphism in a Japanese population. Br. J. Clin. Pharmacol., 29, 111-115.
3. Bozkurt A., Basci N.E., Isimer A., Sayal A., Kayaalp S.O. (1994) : Polymorphic debrisoquine metabolism in a Turkish population. Clin. Pharmacol. Ther., 55, 399-401.
4. Eichelbaum M., Bertilsson L., Sawe J., Zekorn C. (1982) : Polymorphic oxidation as sparteine and debrisoquine: related pharmacogenetic entities. Clin. Pharmacol. Ther., 31, 184-186.
5. McGourthy J.C., Silas J.H., Lennard M.S., Tucker G.T., Woods H.F. (1985) : Metoproiol metabolism and debrisoquine oxidation polymorphism-population and family studies. Br. J. Clin. Pharmacol., 20, 555-566.
6. Basci N.E., Bozkurt A., Isimer A., Kayaalp S.O. (1994) : Correlation between the metabolic ratios of debrisoquine and metoprolol in Turkish subjects. Pharmacol. Toxicol., 75, 62-64.
7. Basci N.E., Brøsen K., Bozkurt A., Isimer A., Sayal A., Kayaalp S.O. (1994) : S-mephenytoin, sparteine and debrisoquine oxidation: genetic polymorphisms in a Turkish population. Br. J. Clin. Pharmacol., 38, 463-465.
8. Woolhouse W.W., Eichelbaum M., Oates N., Idle J.R., Smith R.L. (1985) : Dissociation of coregulatory control of debrisoquine/phenformin and sparteine oxidation in Ghanaians. Clin. Pharmacol. Ther., 37, 512-521.
9. Sommers D.K., Moncrieff J., Avenant J. (1989) : Metoprolol alpha-hydroxylation polymorphism in the San Bushmen of Southern Africa. Hum. Toxicol., 8, 39-43.
10. Iyun A.O., Lennard M.S., Tucker G.T., Woods H.F. (1986) : Metoprolol and debrisoquine metabolism in Nigerians: lack of evidence for polymorphic oxidation. Clin. Pharmacol. Ther., 40, 387-394.
11. Simooya O.O., Njunju E., Hodjegan A.R., Lennard M.S., Tucker G.T. (1993) : Debrisoquine and metoprolol oxidation in Zambians: a population study. Pharmacogenetics, 3, 205-208.
12. Bozkurt A., Basci N.E., Isimer A., Kayaalp S.O. (1993) : Determination of debrisoquine and 4-hydroxydebrisoquine in urine by high performance liquid chromatography with fluorescence detection after solid phase extraction. J. Pharm. Biomed. Anal., 11, 745-749.
13. Evans D.A.P , Harmer D., Downham D.Y., Whirbley E.J., Smith R.L. (1980) : Family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. J. Med. Genet., 17, 102-105.
14. Lennard M.S., Silas J.H. (1983) : Rapid determination of metoprolol in human plasma and urine by high performance liquid chromatography. J. Chromatogr., 272, 205-209.
15. Lam Y.W.F., Rodriguez S.Y. (1993) : High-performance liquid chromatography determination of dextromethorphan and dextrorphan for oxidation phenotyping by fluorescence and ultraviolet detection. Ther. Drug Monit., 15, 300-304.
16. Schmid B., Bircher M.D., Preisig R., Küpfer A. (1985) : Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquine hydroxylation. Clin. Pharmacol. Ther., 38, 618-624.
17. Vinks A., Inaba T., Otton S.V., Kalow W. (1982) : Sparteine metabolism in Canadian Caucasians. Clin. Pharmacol. Ther., 31, 23-29.